Vitura Health Limited (VIT.AX)

0.1050 -0.0200 (-16.00%) At close: 04:10PM AEST

Vitura Health Limited

Suite 8, Level 3
299 Toorak Road
South Yarra, VIC 3141
Australia
61 3 0079 9491
https://vitura.com.au

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Thomas Godfrey Howitt ACIS, AICPA, B.Com., C.A, FTIA	CFO & Company Secretary	473.29k	N/A	1964
Mr. Guy Rothwell Headley	Chief Commercial Officer & Executive Director	473.29k	N/A	N/A
Mr. Ryan J. Tattle	Chief Revenue Officer	347.79k	N/A	N/A
Ms. Kirsty Garrett	Chief Operating Officer	N/A	N/A	N/A
Mr. Jeffrey Lerner	Head of Technology	N/A	N/A	N/A
Ms. Natalie Khoury	Head of Customer Experience	N/A	N/A	N/A
Mr. Ben Cirillo	Financial Controller	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia and Asia. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for medicinal cannabis; CDA Clinics, which provides medicinal cannabis consultations and prescription services; and Cannadoc, a medicinal cannabis clinic that offers telehealth consultations. It also offers psychedelics under the Cortexa brand; and plant-based medications, such as medium chain triglyceride oil and whole flower products under the Adaya brand name. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. The company was incorporated in 2018 and is based in South Yarra, Australia.

Corporate governance

Vitura Health Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.